The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Benzamides; Spiro Compounds; Histone-Lysine N-Methyltransferase; Proto-Oncogene Proteins; Gene Rearrangement; Adolescent; Adult; Aged; Middle Aged; Female; Male
PubMed ID
39121437
PubMed Central ID
PMC11687943
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal